Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Delpharm Acquires Astellas’ Meppel Solid Dosage Production Facilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Delpharm Acquires Astellas’ Meppel Solid Dosage Production Facilities

The site produces more than 40 million finished products packaged annually.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Delpharm, a CDMO, has expanded its pharmaceutical network with the acquisition of Astellas’ Meppel pharmaceutical manufacturing facility in the Netherlands.
 
The fully equipped facility with state-of-the-art technologies is 31,600 square meters and employs 410 qualified personnel who contribute to the production of solid dosage forms, such as tablets, capsules and pellets. The site produces more than 40 million finished products packaged annually.
 
Meppel site holds quality authorizations for exporting medicines globally, including the FDA certification for the U.S., and ISO 14001 and 45001 certifications.
 
“We are delighted to further expand our operations in the Netherland with this 3rd site. Thanks to the Meppel site acquisition, we will strengthen our position in the Netherlands where Delpharm already owns one manufacturing site in Bladel and an injectable drug development centre in Leiden,” said Nicolas Ragot, Managing Director of Delpharm.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics